Rebecca Cleeton

ORCID: 0000-0002-4076-4414
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • SARS-CoV-2 detection and testing
  • SARS-CoV-2 and COVID-19 Research
  • Metabolomics and Mass Spectrometry Studies
  • Liver Diseases and Immunity
  • Pancreatitis Pathology and Treatment
  • Biomedical Research and Pathophysiology
  • Advanced biosensing and bioanalysis techniques
  • Cardiovascular Function and Risk Factors
  • Folate and B Vitamins Research
  • Diet and metabolism studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pancreatic function and diabetes
  • Biosensors and Analytical Detection
  • Pregnancy and preeclampsia studies
  • Drug Transport and Resistance Mechanisms
  • Advanced MRI Techniques and Applications
  • Metabolism and Genetic Disorders
  • Biochemical Analysis and Sensing Techniques
  • COVID-19 and healthcare impacts
  • Cardiovascular Disease and Adiposity
  • Lipid metabolism and disorders
  • Probiotics and Fermented Foods

Emory University
2013-2022

Children's Healthcare of Atlanta
2021-2022

Kenyon College
2009

Pediatric guidelines for the management of nonalcoholic fatty liver disease (NAFLD) recommend a healthy diet as treatment. Reduction sugary foods and beverages is plausible but unproven treatment.To determine effects low in free sugars (those added to occurring naturally fruit juices) adolescent boys with NAFLD.An open-label, 8-week randomized clinical trial aged 11 16 years histologically diagnosed NAFLD evidence active (hepatic steatosis >10% alanine aminotransferase level ≥45 U/L) 1:1 an...

10.1001/jama.2018.20579 article EN JAMA 2019-01-22
Jeffrey B. Schwimmer Joel E. Lavine Laura Wilson Brent A. Neuschwander‐Tetri Stavra A. Xanthakos and 95 more Rohit Kohli Sarah E. Barlow Miriam B. Vos Saul J. Karpen Jean P. Molleston Peter F. Whitington Philip Rosenthal Ajay K. Jain Karen F. Murray Elizabeth M. Brunt David E. Kleiner Mark L. Van Natta Jeanne M. Clark James Tonascia Edward Doo Stephanie H. Abrams Sarah E. Barlow Ryan Himes Rajesh Krisnamurthy Leanel Maldonado Rory Mahabir Kimberlee Bernstein Kristin Bramlage Kim M. Cecil Stephanie DeVore Rohit Kohli Kathleen D. Lake Daniel J. Podberesky Alexander J. Towbin Stavra A. Xanthakos Gerald Behr Joel E. Lavine Jay H. Lefkowitch Ali Mencin Elena Reynoso Adina Alazraki Rebecca Cleeton Saul J. Karpen Jessica Cruz Muños Nicholas Raviele Miriam B. Vos Molly Bozic Oscar W. Cummings Ann Klipsch Jean P. Molleston Sarah Munson Kumar Sandrasegaran Girish Subbarao Kimberly Kafka Ann Scheimann Katie Amsden Mark Fishbein E. OG. Kirwan Saeed Mohammad Cynthia K. Rigsby Lisa Sharda Peter F. Whitington Sarah E. Barlow Jose Derdoy Ajay K. Jain Debra King Pat Osmack Joan Siegner Susan D. Stewart Susan Torretta Kristina Wriston Susan S. Baker Lixin Zhu Jonathon Africa Jorge Angeles Sandra Gómez‐Arroyo Hannah I. Awai Cynthia Behling Craig Bross Janis Durelle Michael S. Middleton Kimberly P. Newton Melissa Paiz Jennifer Sanford Jeffrey B. Schwimmer Claude B. Sirlin Patricia Ugalde‐Nicalo Mariana Dominguez Villarreal Bradley E. Aouizerat Jesse Courtier Linda D. Ferrell Shannon Fleck Ryan M. Gill Camille Langlois Emily R. Perito Philip Rosenthal Patrika Tsai Kara Cooper Simon Horslen Evelyn Hsu

10.1053/j.gastro.2016.08.027 article EN Gastroenterology 2016-08-31
Kimberly P. Newton Haruna S. Feldman Christina Chambers Laura Wilson Cynthia Behling and 95 more Jeanne M. Clark Jean P. Molleston Naga Chalasani Arun J. Sanyal Mark Fishbein Joel E. Lavine Jeffrey B. Schwimmer Stephanie H. Abrams Sarah E. Barlow Ryan Himes Rajesh Krisnamurthy Leanel Maldonado Rory Mahabir April Carr Kimberlee Bernstein Kristin Bramlage Kim M. Cecil Stephanie DeVore Rohit Kohli Kathleen D. Lake Daniel J. Podberesky Alexander J. Towbin Stavra A. Xanthakos Daniela Allende Srinivasan Dasarathy Arthur J. McCullough Mangesh Pagadala Rish K. Pai Cha'Ron Winston Gerald Behr Joel E. Lavine Jay H. Lefkowitch Ali Mencin Elena Reynoso Manal F. Abdelmalek Mustafa R. Bashir Stephanie Buie Anna Mae Diehl Cynthia D. Guy Christopher Kigongo David Malik Yi‐Ping Pan Dawn Piercy Mariko Kopping Tyler Thrasher Adina Alazraki Rebecca Cleeton María Cordero Albert Altés Saul J. Karpen Jessica Cruz Muños Nicholas Raviele Miriam B. Vos Molly Bozic Naga Chalasani Oscar W. Cummings Samer Gawrieh Ann Klipsch Jean P. Molleston Emily Ragozzino Linda Ragozzino Kumar Sandrasegaran Girish Subbarao Raj Vuppalanchi Laura Walker Kimberly Kafka Ann O. Scheimann Joy Ito Mark Fishbein Saeed Mohammad Cynthia K. Rigsby Lisa Sharda Peter F. Whitington Sarah E. Barlow Theresa Cattoor Jose Derdoy Janet Freebersyser Ajay K. Jain Debra King Jinping Lai Pat Osmack Joan Siegner Susan D. Stewart Brent A. Neuschwander‐Tetri Susan Torretta Kristina Wriston F. Assadian Vanessa Barone Maria Cardona Gonzalez Jodie Davila Oren K. Fix Kelly Anne Hennessey Kris V. Kowdley Katherine I. López Erik Ness

10.1016/j.jpeds.2017.03.007 article EN The Journal of Pediatrics 2017-03-30
Stavra A. Xanthakos Joel E. Lavine Katherine P. Yates Jeffrey B. Schwimmer Jean P. Molleston and 95 more Philip Rosenthal Karen F. Murray Miriam B. Vos Ajay K. Jain Ann Scheimann Tamir Miloh Mark Fishbein Cynthia Behling Elizabeth M. Brunt Arun J. Sanyal James Tonascia Stephanie H. Abrams Donna Garner Paula M. Hertel Ryan Himes Alicia Lawson Tamir Miloh Nicole Triggs Kristin Bramlage April Carr Kim M. Cecil Meghan McNeill Marialena Mouzaki Andrew T. Trout Stavra A. Xanthakos Kimberlee Bernstein Stephanie DeVore Rohit Kohli Kathleen D. Lake Daniel J. Podberesky Alexander J. Towbin Joel E. Lavine Ali Mencin Elena Reynoso Adina Alazraki Rebecca Cleeton María Cordero Albert Altés Saul J. Karpen Jessica Cruz Muños Nicholas Raviele Miriam B. Vos Molly Bozic Laura Carr Oscar W. Cummings Kathryn E. Harlow Ann Klipsch Jean P. Molleston Emily Ragozzino Girish S. Rao Kimberly Kafka Ann Scheimann Mark Fishbein Joy Ito Saeed Mohammad Peter F. Whitington Sarah E. Barlow Elizabeth M. Brunt Danielle Carpenter Theresa Cattoor Jose Derdoy Janet Freebersyser Ajay K. Jain Debra King Jinping Lai Joan Siegner Susan D. Stewart Susan Torretta Kristina Wriston Jorge Angeles Jennifer Arin Cynthia Behling Craig Bross Carissa Carrier Jennifer Collins Diana De La Pena Janis Durelle Mary Catherine Huckaby Joel E. Lavine Michael S. Middleton Kimberly P. Newton Jeffrey B. Schwimmer Claude B. Sirlin Patricia Ugalde‐Nicalo Jesse Courtier Ryan M. Gill Camille Langlois Emily R. Perito Philip Rosenthal Patrika Tsai Niviann Blondet Kara Cooper Karen F. Murray Randolph K. Otto Matthew M. Yeh

10.1053/j.gastro.2020.07.034 article EN Gastroenterology 2020-07-23

BACKGROUND. Hepatic de novo lipogenesis (DNL) is elevated in nonalcoholic fatty liver disease (NAFLD). Improvements hepatic fat by dietary sugar reduction may be mediated reduced DNL, but data are limited, especially children. We examined the effects of 8 weeks restriction on DNL adolescents with NAFLD and correlations between other metabolic outcomes.

10.1172/jci150996 article EN Journal of Clinical Investigation 2021-12-14
Jonathan A. Africa Cynthia Behling Elizabeth M. Brunt Nan Zhang Yunjun Luo and 95 more Alan Wells Jiayi Hou Patricia Belt Rohit Kohil Joel E. Lavine Jean P. Molleston Kimberly P. Newton Peter F. Whitington Jeffrey B. Schwimmer Stephanie H. Abrams Sarah E. Barlow Ryan Himes Rajesh Krisnamurthy Leanel Maldonado Rory Mahabir April Carr Kimberlee Bernstein Kristin Bramlage Kim M. Cecil Stephanie DeVore Rohit Kohli Kathleen D. Lake Daniel J. Podberesky Alexander J. Towbin Stavra A. Xanthakos Gerald Behr Joel E. Lavine Jay H. Lefkowitch Ali Mencin Elena Reynoso Adina Alazraki Rebecca Cleeton María Cordero Albert Hernández Saul J. Karpen Jessica Cruz Muños Nicholas Raviele Miriam B. Vos Molly Bozic Oscar W. Cummings Ann Klipsch Jean P. Molleston Emily Ragozzino Kumar Sandrasegaran Girish Subbarao Laura Walker Kimberly Kafka Ann Scheimann Joy Ito Mark Fishbein Saeed Mohammad Cynthia K. Rigsby Lisa Sharda Peter F. Whitington Sarah E. Barlow Theresa Cattoor Jose Derdoy Janet Freebersyser Ajay K. Jain Debra King Jinping Lai Pat Osmack Joan Siegner Susan D. Stewart Susan Torretta Kristina Wriston Susan S. Baker Diana Lopez–Graham Sonja D. Williams Lixin Zhu Jonathan A. Africa Hannah I. Awai Cynthia Behling Craig Bross Jennifer Collins Janis Durelle Kathryn E. Harlow Michael S. Middleton Kimberly P. Newton Melissa Paiz Jeffrey B. Schwimmer Claude B. Sirlin Patricia Ugalde‐Nicalo Mariana Dominguez Villarreal Bradley E. Aouizerat Jesse Courtier Linda D. Ferrell Natasha A. Feier Ryan M. Gill Camille Langlois Emily R. Perito Philip Rosenthal Patrika Tsai Kara Cooper Simon Horslen

10.1016/j.cgh.2017.02.030 article EN Clinical Gastroenterology and Hepatology 2017-03-07

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic in children, but diagnosis challenging due to limited availability of noninvasive biomarkers. Machine learning applied high‐resolution metabolomics and clinical phenotype data offers a novel framework for developing NAFLD screening panel youth. Here, untargeted by liquid chromatography–mass spectrometry was performed on plasma samples from combined cross‐sectional sample children adolescents ages 2‐25 years old with (n =...

10.1002/hep4.1417 article EN cc-by-nc-nd Hepatology Communications 2019-08-13

Background Bacillus subtilis encounters a wide range of environmental pH. The bacteria maintain cytoplasmic pH within narrow range. Response to acid stress is poorly understood function external and permeant acids that conduct protons into the cytoplasm. Methods Principal Findings Cytoplasmic acidification benzoate transcriptome were observed in subtilis. was measured with 4-s time resolution using GFPmut3b fluorimetry. Rapid (pH 7.5 6.0) acidified B. cytoplasm, followed by partial recovery....

10.1371/journal.pone.0008255 article EN cc-by PLoS ONE 2009-12-11
Asma Siddique James E. Nelson Bradley E. Aouizerat Matthew M. Yeh Kris V. Kowdley and 95 more Stephanie H. Abrams Ryan Himes Rajesh Krisnamurthy Leanel Maldonado Beverly A. Morris Patricia Brandt Srinivasan Dasarathy Jaividhya Dasarathy Carol Hawkins Arthur J. McCullough Mangesh Pagadala Rish K. Pai Ruth Sargent Shetal N. Shah Claudia O. Zein Kimberlee Bernstein Kim M. Cecil Stephanie DeVore Rohit Kohli Kathleen D. Lake Daniel J. Podberesky Crystal Slaughter Stavra A. Xanthakos Gerald Behr Joel E. Lavine Ali Mencin Nadia Ovchinsky Elena Reynoso Manal F. Abdelmalek Mustafa R. Bashir Stephanie Buie Anna Mae Diehl Cynthia D. Guy Christopher Kigongo Yi Pan Dawn Piercy Melissa Wagner Adina Alazraki Rebecca Cleeton Saul J. Karpen Nicholas Raviele Miriam B. Vos Elizabeth Byam Naga Chalasani Oscar W. Cummings Cynthia Griggs Fleming Marwan Ghabril Ann Klipsch Smitha Marri Jean P. Molleston Linda Ragozzino Kumar Sandrasegaran Girish Subbarao Raj Vuppalanchi Kimberly Pfeifer Ann O. Scheimann Michael Torbenson Ronen Arnon Mariel Elena Boyd Katie Amsden Mark Fishbein E. OG. Kirwan Saeed Mohammad Ann Quinn Cynthia K. Rigsby Peter F. Whitington Sarah E. Barlow Jose Derdoy Ajay K. Jain Debra King Pat Osmack Joan Siegner Susan D. Stewart Brent A. Neuschwander‐Tetri Dana Romo Brandon Ang Sandra Gómez‐Arroyo Cynthia Behling Archana Bhatt Jennifer Collins Iliana Doycheva Janis Durelle Tarek Hassanein Rohit Loomba Michael S. Middleton Kimberly P. Newton Phirum Nguyen Mazen Noureddin Melissa Paiz Heather Patton Jeffrey B. Schwimmer Claude B. Sirlin Patricia Ugalde‐Nicalo Nathan M. Bass Danielle Brandman

10.1016/j.cgh.2013.11.017 article EN Clinical Gastroenterology and Hepatology 2013-11-21
Kathryn E. Harlow Jonathan A. Africa Alan Wells Patricia Belt Cynthia Behling and 95 more Ajay K. Jain Jean P. Molleston Kimberly P. Newton Philip Rosenthal Miriam B. Vos Stavra A. Xanthakos Joel E. Lavine Jeffrey B. Schwimmer Stephanie H. Abrams Sarah E. Barlow Ryan Himes Rajesh Krisnamurthy Leanel Maldonado Rory Mahabir April Carr Kimberlee Bernstein Kristin Bramlage Kim M. Cecil Stephanie DeVore Rohit Kohli Kathleen D. Lake Daniel J. Podberesky Alexander J. Towbin Gerald Behr Jay H. Lefkowitch Ali Mencin Elena Reynoso Adina Alazraki Rebecca Cleeton María Cordero Albert Altés Saul J. Karpen Jessica Cruz Muños Nicholas Raviele Molly Bozic Oscar W. Cummings Ann Klipsch Emily Ragozzino Kumar Sandrasegaran Girish Subbarao Laura Walker Kimberly Kafka Ann O. Scheimann Joy Ito Mark Fishbein Saeed Mohammad Cynthia K. Rigsby Lisa Sharda Peter F. Whitington Sarah E. Barlow Theresa Cattoor Jose Derdoy Janet Freebersyser Debra King Jinping Lai Pat Osmack Joan Siegner Susan D. Stewart Susan Torretta Kristina Wriston Susan S. Baker Diana Lopez–Graham Sonja D. Williams Lixin Zhu Hannah I. Awai Craig Bross Jennifer Collins Janis Durelle Michael S. Middleton Melissa Paiz Claude B. Sirlin Patricia Ugalde‐Nicalo Mariana Dominguez Villarreal Bradley E. Aouizerat Jesse Courtier Linda D. Ferrell Natasha A. Feier Ryan M. Gill Camille Langlois Emily R. Perito Patrika Tsai Kara Cooper Simon Horslen Evelyn Hsu Karen F. Murray Randolph K. Otto Matthew M. Yeh Melissa Young Elizabeth M. Brunt Kathryn J. Fowler David E. Kleiner Sherry Brown Edward Doo Jay H. Hoofnagle Patricia R. Robuck

10.1016/j.jpeds.2018.02.038 article EN The Journal of Pediatrics 2018-04-13

Background & AimsType 2 diabetes (T2D) is a growing problem in children. Children with NAFLD are at potentially high risk for developing T2D; however, the incidence of T2D this population unknown. This study aimed to determine children and identify associated factors.MethodsChildren enrolled Nonalcoholic Steatohepatitis Clinical Research Network were followed longitudinally. Incidence was determined by using clinical history fasting laboratory values. Cumulative curves developed time T2D. A...

10.1016/j.cgh.2022.05.028 article EN cc-by-nc-nd Clinical Gastroenterology and Hepatology 2022-06-13

Nonalcoholic fatty liver disease (NAFLD) has emerged as the major pediatric chronic disease, and it is estimated to affect more than one third of obese children in U.S. Cardiovascular complications are a leading cause increased mortality adults with NAFLD many adolescents already manifest signs subclinical atherosclerosis including carotid intima-media thickness.Volume intrahepatic fat was assessed 50 Hispanic-American, overweight adolescents, using Magnetic Resonance Spectroscopy....

10.1186/s12944-015-0038-x article EN cc-by Lipids in Health and Disease 2015-04-30

Little is known regarding the subsequent course of non-alcoholic fatty liver disease (NAFLD) diagnosed in childhood. The objectives this single-center study were to gather data on long-term health outcomes and assess feasibility contacting former pediatric patients. In a large medical center, electronic records searched initially identify 162 patients who had biopsy between 2000 2010. Of these, 44 subjects met criteria for age at follow-up (≥18 year) biopsy-proven NAFLD, recruited via postal...

10.3390/children4050034 article EN cc-by Children 2017-05-03

Nonalcoholic fatty liver disease (NAFLD) is the most common in children, and currently, there are no FDA-approved therapies. Plasminogen activator inhibitor-1 (PAI-1) elevated children with NAFLD associated increased severity. Losartan potassium (losartan) an angiotensin II receptor blocker (ARB) that reduces PAI-1 production improves insulin sensitivity has been proposed as a treatment for pediatric but not previously tested. This was 8-week randomized, double-blind, placebo-controlled,...

10.1186/s40814-018-0306-4 article EN cc-by Pilot and Feasibility Studies 2018-06-05

The National Institutes of Health (NIH) launched the Rapid Acceleration Diagnostics (RADxSM) Tech initiative to support development and commercialization novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. primary objective Clinical Studies Core (CSC) was perform SARS-CoV-2 device studies involving diverse populations settings. Within a few months, infrastructure for clinical developed, including master protocol, digital study platform, data...

10.1109/ojemb.2021.3070830 article EN cc-by IEEE Open Journal of Engineering in Medicine and Biology 2021-01-01

Summary Background Non‐alcoholic fatty liver disease (NAFLD) has been shown to be an independent risk factor for cardiovascular disease. In adults, histologic severity of non‐alcoholic steatohepatitis (NASH) is associated with a more atherogenic profile. Objective To assess by lipoprotein profile in children NAFLD and compare assessment severity. Methods Nuclear magnetic resonance including particle sizes, apolipoproteins the insulin resistance (LP‐IR) index was measured serum samples...

10.1111/ijpo.12648 article EN Pediatric Obesity 2020-05-04

ObjectivesTo determine SARS-CoV-2-antibody prevalence in pediatric healthcare workers (pHCWs).DesignBaseline of anti-SARS-CoV-2-IgG was assessed a prospective cohort study from large facility. Prior SARS-CoV-2 testing history, potential risk factors and anxiety level about COVID-19 were determined. Prevalence difference between emergency department (ED)-based non-ED-pHCWs modeled controlling for those covariates. Chi-square test-for-trend used to examine by month enrollment.ResultsMost 642...

10.1016/j.ijid.2021.03.017 article EN cc-by-nc-nd International Journal of Infectious Diseases 2021-03-14

Abstract There is an increasing need to understand long‐term metabolic changes and resultant comorbidities because life expectancy after pediatric kidney liver transplants. We evaluated differences in classic novel cardiometabolic biomarkers among obese normal weight adolescent transplant recipients. enrolled a total of 80 (mean±SD, 14.8 years ±3.0) recipients (63 kidney, 17 liver) with mean duration from transplantation 6.0 (±4.1) years. Among recipients, overweight individuals had higher...

10.1111/petr.12984 article EN Pediatric Transplantation 2017-07-17

Nonalcoholic fatty liver disease (NAFLD) is a common chronic in children and may lead to cirrhosis requiring transplant. Thus, prompt diagnosis of advanced fibrosis essential. Our objectives were examine PRO‐C3 (a neo‐epitope pro‐peptide type III collagen formation) levels across childhood/adolescence associations with pediatric NAFLD. This cross‐sectional study included 88 adolescents biopsy‐proven NAFLD (mean age: 13.9 ± 2.9 years, 71% male) 65 healthy participants (11.8 4.5 38% male)....

10.1002/hep4.1766 article EN Hepatology Communications 2021-07-08

Pediatric liver transplantation rejection affects 20% of children. Currently, biopsy, expensive and invasive, is the best method diagnosis. Discovery validation clinical biomarkers from blood or other biospecimens would improve care. For this study, stored plasma samples were utilized two cross-sectional cohorts transplant patients at Children's Healthcare Atlanta. High resolution metabolic profiling was completed using established methods. Children with (n = 18) without 25) acute cellular...

10.1038/s41598-022-18957-4 article EN cc-by Scientific Reports 2022-11-04

Context.— Diagnostic testing for SARS-CoV-2 in symptomatic and asymptomatic children remains integral to care, particularly supporting return attendance schools. The concordance of detection children, using various specimen types, has not been widely studied. Objective.— To compare 3 sample types polymerase chain reaction (PCR) collected tested at a single facility. Design.— We prospectively recruited 142 children/young adults into comparison study performed health care system. Each child...

10.5858/arpa.2021-0625-sa article EN Archives of Pathology & Laboratory Medicine 2022-05-16

Background & Aims Magnetic resonance-based steatosis measurement of the liver has become non-invasive gold standard; however very few diagnostic thresholds have been independently validated and none in children. This study was designed to validate thresholds, assess repeatability relationship histology a proprietary MRI volumetric fat fraction (VLFF) method (HepaFat-Scan®) magnetic resonance spectroscopy (MRS) proton density (PDFF) method. Methods cross-sectional assesses accuracy MRI-VLFF...

10.1002/ygh2.410 article EN GastroHep 2020-06-27
Coming Soon ...